72 related articles for article (PubMed ID: 7026276)
1. ["Partner control" method of twin studies in evaluating the hemodynamic effects of nonachlazine].
Zaslavskaia RM; Zolotaia RD; Lil'in ET
Farmakol Toksikol; 1981; 44(3):357-60. PubMed ID: 7026276
[No Abstract] [Full Text] [Related]
2. [System of methodological approaches to assessing and predicting the hemodynamic effects of hypotensive and antianginal agents].
Zaslavskaia RM; Zolotaia RD; Trubnikov VI
Farmakol Toksikol; 1982; 45(4):110-4. PubMed ID: 6889983
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
[TBL] [Abstract][Full Text] [Related]
4. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
Pilipchuk DB; Berger DIa; Sapozhkov AV
Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of nonachlazine in ischemic heart disease under ambulatory conditions].
Glezer GA; Shraĭber NM; Pak GP; Moskalenko NP
Kardiologiia; 1980 Jul; 20(7):53-6. PubMed ID: 7401440
[TBL] [Abstract][Full Text] [Related]
6. [Effect of nonachlazine on the energy provision for cardiac contractile activity in experimental myocardial infarct].
Reznikov KM; Provotorova PP; Sidel'nikova VI
Farmakol Toksikol; 1982; 45(5):52-7. PubMed ID: 7140956
[TBL] [Abstract][Full Text] [Related]
7. [Anti-inflammatory action of nonachlazine, a new circulatory drug].
Krupińska J; Kawierina NW; Cebo B
Folia Med Cracov; 1981; 23(2):289-95. PubMed ID: 7047323
[No Abstract] [Full Text] [Related]
8. [Use of mathematical methods of analysis of ECG data for evaluating the effectiveness of treatment of alcoholic cardiomyopathies with preparations of the phenothiazine group].
Mel'nikova TS; Berdiaev SIu; Kaverina NV
Kardiologiia; 1986 Apr; 26(4):88-9. PubMed ID: 3520092
[No Abstract] [Full Text] [Related]
9. [Nonachlazine in solution as an arresting agent in stenocardiac attacks].
Boĭko SS; Kaverina NV; Liubimov BI; Markova GA; Mitrofanov VS
Farmakol Toksikol; 1979; 42(3):243-7. PubMed ID: 446702
[TBL] [Abstract][Full Text] [Related]
10. [Action of nonachlazine on the creatine phosphokinase and acid phosphatase activity and on the lysosomal membrane stability of the ischemic myocardium in rats after preliminary reserpinization].
Sysoliatina NA
Farmakol Toksikol; 1986; 49(4):77-81. PubMed ID: 3758337
[TBL] [Abstract][Full Text] [Related]
11. [Use of nonachlazine in the treatment of chronic ischemic heart disease].
Evtushenko VI; Zakharov NM; Knysh VI; Martynov VI
Voen Med Zh; 1979 Mar; (3):59-60. PubMed ID: 452467
[No Abstract] [Full Text] [Related]
12. [Certain debatable questions concerning the use of nonachlazine in patients with chronic ischemic heart disease].
Iagus KhK
Ter Arkh; 1980; 52(9):97-101. PubMed ID: 7434242
[No Abstract] [Full Text] [Related]
13. [Effect of nonachlazine on the echocardiographic parameters in patients with post-infarct cardiosclerosis].
Iagus KhK
Ter Arkh; 1980; 52(5):42-6. PubMed ID: 7404363
[No Abstract] [Full Text] [Related]
14. [Use of beta 1-adrenostimulants in circulatory failure in patients with chronic inflammatory lung diseases].
Gavrisiuk VK; Morskaia ND; Iachnik AI; Morozova NA; Iakhnitsia TV
Kardiologiia; 1990 Mar; 30(3):32-5. PubMed ID: 2199719
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of the inotropic action of nonachlazine].
Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI
Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nonachlazine on the cardiac component of baroreceptor reflexes in unanesthetized cats].
Medvedev OS; Stepochkina NA; Matsievskiĭ DD
Biull Eksp Biol Med; 1980 Sep; 90(9):309-11. PubMed ID: 7426732
[TBL] [Abstract][Full Text] [Related]
17. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
Tereshchenko VP
Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
[No Abstract] [Full Text] [Related]
18. [Effect of nonachlazine on brain and myocardial noradrenaline content in normal rats and rats subjected to stress].
Turilova AI; Bendikov EA
Biull Eksp Biol Med; 1981 May; 91(5):580-2. PubMed ID: 7260390
[TBL] [Abstract][Full Text] [Related]
19. [Effect of nonachlazine on ATP, ADP, and lactic acid concentration in intact and ischemic myocardium].
Turilova AI; Azvolinskaia TN; Kryzhanovskiĭ SA
Biull Eksp Biol Med; 1980 Jul; 89(7):49-51. PubMed ID: 7407371
[TBL] [Abstract][Full Text] [Related]
20. [Use of computers for detecting the dynamics of changes in the cardiac adaptation reserves of alcoholism patients treated with nonachlazine].
Kaverina NV; Berdiaev SIu; Mel'nikova TS
Biull Eksp Biol Med; 1982 May; 93(5):68-72. PubMed ID: 7046840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
